NYSE - Delayed Quote USD

Koninklijke Philips N.V. (PHG)

Compare

32.27

+0.14

(+0.44%)

At close: October 16 at 4:00 PM EDT

Report Name

Direction

Rating

Price Target

Morningstar ?Stock Picks ?19 days ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Direction -

Rating -

Price Target -

Morningstar ?Analyst Report ?21 days ago

Koninklijke Philips N.V.: Philips' Diagnostic Imaging Business on the Path to Growth

Direction

Rating

Price Target

Morningstar ?Analyst Report ?last month

Koninklijke Philips N.V.: Reinitiating on Philips: Upgrading to Wide Moat and Raising Fair Value Estimate

Direction

Rating

Price Target

Morningstar ?Analyst Report ?2 months ago

Koninklijke Philips N.V.: Philips Earnings: Moving Beyond Calamity

Direction

Rating

Price Target

Morningstar ?Analyst Report ?3 months ago

Koninklijke Philips N.V.: Litigation Settlement Should Offer Some Stability for Philips

Direction

Rating

Price Target

Morningstar ?Analyst Report ?3 months ago

Koninklijke Philips N.V.: Philips' Settlement Removes Some Uncertainty

Direction

Rating

Price Target

Morningstar ?Analyst Report ?4 months ago

Koninklijke Philips N.V.: Philips Earnings: Reaches $1.1 Billion Settlement Agreement; Maintaining EUR 21 Fair Value Estimate

Direction

Rating

Price Target

Morningstar ?Analyst Report ?8 months ago

Koninklijke Philips N.V.: Philips Earnings: New Restrictions Weigh on Sleep and Respiratory Business; Fair Value Down 16%

Direction

Rating

Price Target

Morningstar ?Analyst Report ?9 months ago

Koninklijke Philips N.V.: Philips Shares Undervalued, but Raising Uncertainty Rating to High

Direction

Rating

Price Target

Morningstar ?Analyst Report ?11 months ago

Koninklijke Philips N.V.: Philips Earnings: Strong Profit Offset by Decline in Orders; Maintain Our EUR 25 Fair Value Estimate

Direction

Rating

Price Target

Morningstar ?Analyst Report ?last year

Koninklijke Philips N.V.: Philips Earnings: Beats Expectations and Lifts 2023 Outlook, but Uncertainty Weighs on Shares

Direction

Rating

Price Target

Morningstar ?Analyst Report ?last year

Koninklijke Philips N.V.: Philips Earnings: Stock Rises 11% After Beating Consensus; Diagnostics and Treatment the Outlier

Direction

Rating

Price Target

Morningstar ?Analyst Report ?last year

Koninklijke Philips N.V.: Philips Cuts 6,000 More Jobs, but Still Has To Prove Its Turnaround Strategy; Maintain EUR 25 FVE

Direction

Rating

Price Target

Morningstar ?Analyst Report ?last year

Koninklijke Philips N.V.: Philips' Third Quarter Weak, as Anticipated Last Week

Direction

Rating

Price Target

Morningstar ?Analyst Report ?last year

Koninklijke Philips N.V.: Reducing Our Philips FVE to EUR 25; We Believe Management Has a Real Credibility Issue

Direction

Rating

Price Target

Morningstar ?Analyst Report ?2 years ago

Koninklijke Philips N.V.: Headwinds Still Hurt Philips in Q2, and We Take Guidance With a Grain of Salt; Reducing FVE

Direction

Rating

Price Target

Morningstar ?Analyst Report ?2 years ago

Koninklijke Philips N.V.: Philips Gathers a Set of Different Medium-Term Risks; Trimming FVE to EUR 35

Direction

Rating

Price Target

Morningstar ?Analyst Report ?2 years ago

Koninklijke Philips N.V.: Philips Finishes a Turbulent 2021; Uncertainty Still High During 2022; Maintaining FVE

Direction

Rating

Price Target

SNN Smith & Nephew plc

28.86

+1.37%

BSX Boston Scientific Corporation

87.00

+0.27%

EW Edwards Lifesciences Corporation

68.30

-0.87%

STE STERIS plc

225.99

-0.31%

SYK Stryker Corporation

361.31

+0.65%

BRKR Bruker Corporation

61.27

-2.92%

LIVN LivaNova PLC

53.19

-0.89%

BIO Bio-Rad Laboratories, Inc.

329.79

-3.62%

MDT Medtronic plc

89.99

+0.17%

QDEL QuidelOrtho Corporation

39.98

-0.55%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Koninklijke Philips N.V. (PHG)

Research Reports: PHG

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Koninklijke Philips N.V.: Philips' Diagnostic Imaging Business on the Path to Growth

Koninklijke Philips N.V.: Reinitiating on Philips: Upgrading to Wide Moat and Raising Fair Value Estimate

Koninklijke Philips N.V.: Philips Earnings: Moving Beyond Calamity

Koninklijke Philips N.V.: Litigation Settlement Should Offer Some Stability for Philips

Koninklijke Philips N.V.: Philips' Settlement Removes Some Uncertainty

Koninklijke Philips N.V.: Philips Earnings: Reaches $1.1 Billion Settlement Agreement; Maintaining EUR 21 Fair Value Estimate

Koninklijke Philips N.V.: Philips Earnings: New Restrictions Weigh on Sleep and Respiratory Business; Fair Value Down 16%

Koninklijke Philips N.V.: Philips Shares Undervalued, but Raising Uncertainty Rating to High

Koninklijke Philips N.V.: Philips Earnings: Strong Profit Offset by Decline in Orders; Maintain Our EUR 25 Fair Value Estimate

Koninklijke Philips N.V.: Philips Earnings: Beats Expectations and Lifts 2023 Outlook, but Uncertainty Weighs on Shares

Koninklijke Philips N.V.: Philips Earnings: Stock Rises 11% After Beating Consensus; Diagnostics and Treatment the Outlier

Koninklijke Philips N.V.: Philips Cuts 6,000 More Jobs, but Still Has To Prove Its Turnaround Strategy; Maintain EUR 25 FVE

Koninklijke Philips N.V.: Philips' Third Quarter Weak, as Anticipated Last Week

Koninklijke Philips N.V.: Reducing Our Philips FVE to EUR 25; We Believe Management Has a Real Credibility Issue

Koninklijke Philips N.V.: Headwinds Still Hurt Philips in Q2, and We Take Guidance With a Grain of Salt; Reducing FVE

Koninklijke Philips N.V.: Philips Gathers a Set of Different Medium-Term Risks; Trimming FVE to EUR 35

Koninklijke Philips N.V.: Philips Finishes a Turbulent 2021; Uncertainty Still High During 2022; Maintaining FVE

Related Tickers